Search by Drug Name or NDC

    NDC 41250-0663-05 Cold and Flu Severe 325; 10; 200; 5 mg/1; mg/1; mg/1; mg/1 Details

    Cold and Flu Severe 325; 10; 200; 5 mg/1; mg/1; mg/1; mg/1

    Cold and Flu Severe is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Meijer. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 41250-0663
    Product ID 41250-663_d070f7d1-5460-4d9c-e053-2a95a90a973d
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Cold and Flu Severe
    Proprietary Name Suffix n/a
    Non-Proprietary Name ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 325; 10; 200; 5
    Active Ingredient Units mg/1; mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Meijer
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 41250-0663-05 (41250066305)

    NDC Package Code 41250-663-05
    Billing NDC 41250066305
    Package 2 BLISTER PACK in 1 CARTON (41250-663-05) / 12 TABLET, COATED in 1 BLISTER PACK
    Marketing Start Date 2015-01-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 9af0df8b-08a7-46b5-8fbb-7cded91cf040 Details

    Revised: 11/2021